标题
Alternative metrics for assessing clinical benefit with immunotherapy in oncology
作者
关键词
-
出版物
OncoImmunology
Volume -, Issue -, Pages e1343774
出版商
Informa UK Limited
发表日期
2017-08-31
DOI
10.1080/2162402x.2017.1343774
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Evaluation of baseline serum C-reactive protein (CRP) and benefit from tremelimumab compared to chemotherapy in first-line melanoma.
- (2017) M. A. Marshall et al. JOURNAL OF CLINICAL ONCOLOGY
- Immune-related response evaluations during immune-checkpoint inhibitor therapy: establishing a “common language” for the new arena of cancer treatment
- (2016) Mizuki Nishino Journal for ImmunoTherapy of Cancer
- Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
- (2015) Dirk Schadendorf et al. JOURNAL OF CLINICAL ONCOLOGY
- Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma
- (2015) Sagar Lonial et al. NEW ENGLAND JOURNAL OF MEDICINE
- Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma
- (2015) A. Keith Stewart et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab versus Ipilimumab in Advanced Melanoma
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Which Metrics Are Appropriate to Describe the Value of New Cancer Therapies?
- (2015) Peter Johnson et al. Biomed Research International
- Durable benefit and the potential for long-term survival with immunotherapy in advanced melanoma
- (2014) David McDermott et al. CANCER TREATMENT REVIEWS
- Immuno-oncology Combinations: A Review of Clinical Experience and Future Prospects
- (2014) S. J. Antonia et al. CLINICAL CANCER RESEARCH
- Dasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: clinical results from a randomised phase-2 study (NordCML006)
- (2014) Henrik Hjorth-Hansen et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- What have we learned from cancer immunotherapy in the last 3 years?
- (2014) Paolo A Ascierto et al. Journal of Translational Medicine
- Mean overall survival gain with aflibercept plus FOLFIRI vs placebo plus FOLFIRI in patients with previously treated metastatic colorectal cancer
- (2013) F Joulain et al. BRITISH JOURNAL OF CANCER
- Phase III Randomized Clinical Trial Comparing Tremelimumab With Standard-of-Care Chemotherapy in Patients With Advanced Melanoma
- (2013) Antoni Ribas et al. JOURNAL OF CLINICAL ONCOLOGY
- Statistical issues and challenges in immuno-oncology
- (2013) Tai-Tsang Chen Journal for ImmunoTherapy of Cancer
- Matching-Adjusted Indirect Comparisons: A New Tool for Timely Comparative Effectiveness Research
- (2012) James E. Signorovitch et al. VALUE IN HEALTH
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
- (2009) J. D. Wolchok et al. CLINICAL CANCER RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now